345 related articles for article (PubMed ID: 17616354)
1. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
McKnight AJ; Maxwell AP; Patterson CC; Brady HR; Savage DA
J Diabetes Complications; 2007; 21(4):242-5. PubMed ID: 17616354
[TBL] [Abstract][Full Text] [Related]
2. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
[TBL] [Abstract][Full Text] [Related]
3. Role of alpha-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy.
Conway BR; Martin R; McKnight AJ; Savage DA; Brady HR; Maxwell AP
Nephrol Dial Transplant; 2004 Aug; 19(8):2019-24. PubMed ID: 15187197
[TBL] [Abstract][Full Text] [Related]
4. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
[TBL] [Abstract][Full Text] [Related]
5. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy.
Chen JW; Hansen PM; Tarnow L; Hellgren A; Deckert T; Pociot F
Diabet Med; 1997 Feb; 14(2):143-7. PubMed ID: 9047092
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.
Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Akgül C; Uysal M
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):57-60. PubMed ID: 19631445
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses.
Nagy B; Savli H; Molvarec A; Várkonyi T; Rigó B; Hupuczi P; Rigó J
Clin Chim Acta; 2008 Mar; 389(1-2):126-31. PubMed ID: 18167313
[TBL] [Abstract][Full Text] [Related]
10. Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes.
Martin RJ; Savage DA; Patterson CC; Brady HR; Maxwell AP
Diabet Med; 2007 Mar; 24(3):259-65. PubMed ID: 17263760
[TBL] [Abstract][Full Text] [Related]
11. An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy.
Loughrey BV; Maxwell AP; Fogarty DG; Middleton D; Harron JC; Patterson CC; Darke C; Savage DA
Cytokine; 1998 Dec; 10(12):984-8. PubMed ID: 10049523
[TBL] [Abstract][Full Text] [Related]
12. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
13. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
Lajer M; Tarnow L; Fleckner J; Hansen BV; Edwards DG; Parving HH; Boel E
Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.
Kang S; Zhao J; Liu Q; Zhou R; Wang N; Li Y
Environ Mol Mutagen; 2009 Jun; 50(5):361-6. PubMed ID: 19197986
[TBL] [Abstract][Full Text] [Related]
15. The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.
Schön S; Prante C; Bahr C; Tarnow L; Kuhn J; Kleesiek K; Götting C
Diabetes Care; 2006 Oct; 29(10):2295-9. PubMed ID: 17003309
[TBL] [Abstract][Full Text] [Related]
16. Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis.
Xu M; Chen X; Yan L; Cheng H; Chen W
J Mol Endocrinol; 2008 May; 40(5):243-51. PubMed ID: 18434430
[TBL] [Abstract][Full Text] [Related]
17. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.
Patel A; Scott WR; Lympany PA; Rippin JD; Gill GV; Barnett AH; Bain SC;
Diabet Med; 2005 Jan; 22(1):69-73. PubMed ID: 15606694
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
[TBL] [Abstract][Full Text] [Related]
19. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection.
Hussein A; Askar E; Elsaeid M; Schaefer F
Nephrol Dial Transplant; 2010 Mar; 25(3):779-85. PubMed ID: 19861314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
